In the mouse model of bacterial infection, evodiamine efficiently increased the serum levels of IL-1β, TNF-α and IFN-γ, thus potentiating the innate immune responses to enhance the clearance of bacteria and dampening the infiltration of inflammatory cells in the liver. Here, IL1B is linked to bacterial infectious disease.